Enhanced neutrophil emigration and Porphyromonas gingivalis reduction following PGG-glucan treatment of mice

Richard Niederman, Hans Kelderman, Sigmund Socransky, Gary Ostroff, Caroline Genco, Ralph Kent, Philip Stashenko

Research output: Contribution to journalArticle

Abstract

Periodontal disease is the consequence of a mixed Gram-negative infection in the gingival sulcus and has been associated with deficits in the neutrophil response. A novel, and heretofore untested, alternative approach to therapy is the use of biological-response modulators that enhance the neutrophil response. Poly-β1-6-glucotriosyl-β1-3-glucopyranose glucan (PGG-glucan) is an immunomodulator, derived from yeast, which specifically enhances neutrophil priming, phagocytosis and bacterial killing while failing to induce inflammatory cytokine expression. The hypothesis tested was that PGG-glucan could enhance host resistance to a Gram-negative periodontal pathogen, Porphyromonas gingivalis. Chambers were implanted subcutaneously in the dorsolumbar region of C57BL/6J mice and allowed to heal for 14 days. PGG-glucan was administered subcutaneously to one-half of the animals and saline to the other half. In the first set of experiments the chambers were inoculated with P. gingivalis (A7436) at 4 × 106, 4 × 107, and 4 × 108 colony-forming units (CFU). In the second set of experiments the chambers were inoculated with 5 × 108 CFU of either P. gingivalis or Streptococcus sanguis, a Gram-positive oral microbe that is not periodontopathic. Chambers were sampled over the following 2 weeks. The results demonstrated that: (1) bacterial CFU and neutrophils increased with increasing bacterial inoculum (P < 0.02); (2) bacterial CFU were lower in the PGG-glucan-treated animals than in the saline controls (P < 0.02); and (3) neutrophil counts were higher in the PGG-glucan-treated animals than in the saline controls (P < 0.01). These results indicate that PGG-glucan significantly enhances neutrophil emigration and bacterial killing, thus decreasing the bacterial infection in this model system.

Original languageEnglish (US)
Pages (from-to)613-618
Number of pages6
JournalArchives of Oral Biology
Volume47
Issue number8
DOIs
StatePublished - Aug 2002

Fingerprint

Porphyromonas gingivalis
Glucans
Emigration and Immigration
Neutrophils
Stem Cells
Streptococcus sanguis
Immunologic Factors
Periodontal Diseases
Inbred C57BL Mouse
Phagocytosis
Bacterial Infections
Yeasts
Cytokines
Infection

Keywords

  • Bacterial infection
  • Immunomodulation
  • Neutrophils
  • P. gingivalis

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Enhanced neutrophil emigration and Porphyromonas gingivalis reduction following PGG-glucan treatment of mice. / Niederman, Richard; Kelderman, Hans; Socransky, Sigmund; Ostroff, Gary; Genco, Caroline; Kent, Ralph; Stashenko, Philip.

In: Archives of Oral Biology, Vol. 47, No. 8, 08.2002, p. 613-618.

Research output: Contribution to journalArticle

Niederman, Richard ; Kelderman, Hans ; Socransky, Sigmund ; Ostroff, Gary ; Genco, Caroline ; Kent, Ralph ; Stashenko, Philip. / Enhanced neutrophil emigration and Porphyromonas gingivalis reduction following PGG-glucan treatment of mice. In: Archives of Oral Biology. 2002 ; Vol. 47, No. 8. pp. 613-618.
@article{8dd2510467d54302af1ff22d67b869c3,
title = "Enhanced neutrophil emigration and Porphyromonas gingivalis reduction following PGG-glucan treatment of mice",
abstract = "Periodontal disease is the consequence of a mixed Gram-negative infection in the gingival sulcus and has been associated with deficits in the neutrophil response. A novel, and heretofore untested, alternative approach to therapy is the use of biological-response modulators that enhance the neutrophil response. Poly-β1-6-glucotriosyl-β1-3-glucopyranose glucan (PGG-glucan) is an immunomodulator, derived from yeast, which specifically enhances neutrophil priming, phagocytosis and bacterial killing while failing to induce inflammatory cytokine expression. The hypothesis tested was that PGG-glucan could enhance host resistance to a Gram-negative periodontal pathogen, Porphyromonas gingivalis. Chambers were implanted subcutaneously in the dorsolumbar region of C57BL/6J mice and allowed to heal for 14 days. PGG-glucan was administered subcutaneously to one-half of the animals and saline to the other half. In the first set of experiments the chambers were inoculated with P. gingivalis (A7436) at 4 × 106, 4 × 107, and 4 × 108 colony-forming units (CFU). In the second set of experiments the chambers were inoculated with 5 × 108 CFU of either P. gingivalis or Streptococcus sanguis, a Gram-positive oral microbe that is not periodontopathic. Chambers were sampled over the following 2 weeks. The results demonstrated that: (1) bacterial CFU and neutrophils increased with increasing bacterial inoculum (P < 0.02); (2) bacterial CFU were lower in the PGG-glucan-treated animals than in the saline controls (P < 0.02); and (3) neutrophil counts were higher in the PGG-glucan-treated animals than in the saline controls (P < 0.01). These results indicate that PGG-glucan significantly enhances neutrophil emigration and bacterial killing, thus decreasing the bacterial infection in this model system.",
keywords = "Bacterial infection, Immunomodulation, Neutrophils, P. gingivalis",
author = "Richard Niederman and Hans Kelderman and Sigmund Socransky and Gary Ostroff and Caroline Genco and Ralph Kent and Philip Stashenko",
year = "2002",
month = "8",
doi = "10.1016/S0003-9969(02)00042-0",
language = "English (US)",
volume = "47",
pages = "613--618",
journal = "Archives of Oral Biology",
issn = "0003-9969",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - Enhanced neutrophil emigration and Porphyromonas gingivalis reduction following PGG-glucan treatment of mice

AU - Niederman, Richard

AU - Kelderman, Hans

AU - Socransky, Sigmund

AU - Ostroff, Gary

AU - Genco, Caroline

AU - Kent, Ralph

AU - Stashenko, Philip

PY - 2002/8

Y1 - 2002/8

N2 - Periodontal disease is the consequence of a mixed Gram-negative infection in the gingival sulcus and has been associated with deficits in the neutrophil response. A novel, and heretofore untested, alternative approach to therapy is the use of biological-response modulators that enhance the neutrophil response. Poly-β1-6-glucotriosyl-β1-3-glucopyranose glucan (PGG-glucan) is an immunomodulator, derived from yeast, which specifically enhances neutrophil priming, phagocytosis and bacterial killing while failing to induce inflammatory cytokine expression. The hypothesis tested was that PGG-glucan could enhance host resistance to a Gram-negative periodontal pathogen, Porphyromonas gingivalis. Chambers were implanted subcutaneously in the dorsolumbar region of C57BL/6J mice and allowed to heal for 14 days. PGG-glucan was administered subcutaneously to one-half of the animals and saline to the other half. In the first set of experiments the chambers were inoculated with P. gingivalis (A7436) at 4 × 106, 4 × 107, and 4 × 108 colony-forming units (CFU). In the second set of experiments the chambers were inoculated with 5 × 108 CFU of either P. gingivalis or Streptococcus sanguis, a Gram-positive oral microbe that is not periodontopathic. Chambers were sampled over the following 2 weeks. The results demonstrated that: (1) bacterial CFU and neutrophils increased with increasing bacterial inoculum (P < 0.02); (2) bacterial CFU were lower in the PGG-glucan-treated animals than in the saline controls (P < 0.02); and (3) neutrophil counts were higher in the PGG-glucan-treated animals than in the saline controls (P < 0.01). These results indicate that PGG-glucan significantly enhances neutrophil emigration and bacterial killing, thus decreasing the bacterial infection in this model system.

AB - Periodontal disease is the consequence of a mixed Gram-negative infection in the gingival sulcus and has been associated with deficits in the neutrophil response. A novel, and heretofore untested, alternative approach to therapy is the use of biological-response modulators that enhance the neutrophil response. Poly-β1-6-glucotriosyl-β1-3-glucopyranose glucan (PGG-glucan) is an immunomodulator, derived from yeast, which specifically enhances neutrophil priming, phagocytosis and bacterial killing while failing to induce inflammatory cytokine expression. The hypothesis tested was that PGG-glucan could enhance host resistance to a Gram-negative periodontal pathogen, Porphyromonas gingivalis. Chambers were implanted subcutaneously in the dorsolumbar region of C57BL/6J mice and allowed to heal for 14 days. PGG-glucan was administered subcutaneously to one-half of the animals and saline to the other half. In the first set of experiments the chambers were inoculated with P. gingivalis (A7436) at 4 × 106, 4 × 107, and 4 × 108 colony-forming units (CFU). In the second set of experiments the chambers were inoculated with 5 × 108 CFU of either P. gingivalis or Streptococcus sanguis, a Gram-positive oral microbe that is not periodontopathic. Chambers were sampled over the following 2 weeks. The results demonstrated that: (1) bacterial CFU and neutrophils increased with increasing bacterial inoculum (P < 0.02); (2) bacterial CFU were lower in the PGG-glucan-treated animals than in the saline controls (P < 0.02); and (3) neutrophil counts were higher in the PGG-glucan-treated animals than in the saline controls (P < 0.01). These results indicate that PGG-glucan significantly enhances neutrophil emigration and bacterial killing, thus decreasing the bacterial infection in this model system.

KW - Bacterial infection

KW - Immunomodulation

KW - Neutrophils

KW - P. gingivalis

UR - http://www.scopus.com/inward/record.url?scp=0036694807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036694807&partnerID=8YFLogxK

U2 - 10.1016/S0003-9969(02)00042-0

DO - 10.1016/S0003-9969(02)00042-0

M3 - Article

VL - 47

SP - 613

EP - 618

JO - Archives of Oral Biology

JF - Archives of Oral Biology

SN - 0003-9969

IS - 8

ER -